Integrichain Blog


September 18, 2023

Medicaid Drug Rebate Program


IntegriChain is proud to be a sponsor of this year’s Medicaid Drug Rebate Program (MDRP) event, providing one session of thought leadership to this year’s agenda. To connect with Jeff, or get more information on Medicaid Drug Rebate, please send our pharma operational consultants a message here.  

Vice President, Operational Consulting

Jeff Baab
Vice President, Operational Consulting

Session Date: Tuesday, September 19
Session Time: 11:10AM – 11:50AM
Session #1:
The Challenges of Innovation: Operational and R&D Uncertainty from the IRA

Session Description: In this session, Jeff Baab, Vice President of Operational Consulting, Judd Caulfield, Lead Counsel of the Oncology Business Unit at Takeda Pharmaceuticals and Harmeet Dhillon, Head of Public Policy at GlaxoSmithKline will cover topics including: 

  • Where we are in the process of operationalizing the IRA and what has happened since the most recent comment period.
  • Insights into the selection of drugs up for negotiation and why they were selected
  • 80% of Pharma is reconsidering R&D of new products because of the IRA – considerations for manufacturers

For more on the topics in this presentation, please read our consulting blog post on the Inflation Reduction Act Impact on R&D.

Register here.


adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article